| RS1962537574 |
SMAD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS1962538901 |
SMAD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aneurysm-osteoarthritis syndrome |
| RS1962580119 |
MMP2
|
Health Risk |
Pathogenic |
Multicentric osteolysis nodulosis arthropathy spectrum, Multicentric osteolysis nodulosis arthropathy spectrum |
| RS1962591629 |
COL4A4
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Alport syndrome |
| RS1962602493 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1962602688 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1962628992 |
COL4A4
|
Health Risk |
Pathogenic |
Chronic kidney disease, Autosomal recessive Alport syndrome |
| RS1962651394 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Hematuria |
| RS1962955145 |
COQ7
|
Health Risk |
Likely pathogenic |
Primary coenzyme Q10 deficiency 8, Primary coenzyme Q10 deficiency 8 |
| RS1962974502 |
FA2H
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1962978296 |
FA2H
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1962978958 |
FA2H
|
Health Risk |
Pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia 35 |
| RS1963032146 |
SCNN1B
|
Health Risk |
Pathogenic |
— |
| RS1963050712 |
SMAD3
|
Health Risk |
Likely pathogenic |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS1963178887 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1963180892 |
SMAD3
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Thoracic aortic aneurysm or dissection |
| RS1963213617 |
COG7
|
Health Risk |
Conflicting classifications of pathogenicity |
COG7 congenital disorder of glycosylation, Inborn genetic diseases |
| RS1963248804 |
USB1
|
Health Risk |
Pathogenic |
— |
| RS1963314793 |
COG7
|
Health Risk |
Pathogenic |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS1963331116 |
SMAD3
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1963334285 |
SMAD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1963334413 |
SMAD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1963370785 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1963371063 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS1963372273 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1963379793 |
COL4A4
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1963392922 |
COL4A4
|
Health Risk |
Pathogenic |
Alport syndrome, Autosomal recessive Alport syndrome |
| RS1963393226 |
ATP2A1
|
Health Risk |
Pathogenic |
Brody myopathy, Brody myopathy |
| RS1963402519 |
COL4A4
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1963420059 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1963445391 |
PARN
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 6 |
| RS1963449829 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiomyopathy |
| RS1963456518 |
ATP2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Brody myopathy, Brody myopathy |
| RS1963459711 |
COG7
|
Health Risk |
Pathogenic |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS1963501754 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS1963564019 |
USB1
|
Health Risk |
Likely pathogenic |
— |
| RS1963565243 |
USB1
|
Health Risk |
Pathogenic |
— |
| RS1963620354 |
KIF7
|
Health Risk |
Pathogenic |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS1963635852 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS1963639188 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1963639299 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1963641493 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1963646325 |
KIF7
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple epiphyseal dysplasia, Al-Gazali type |
| RS1963653131 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1963656730 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1963666828 |
COG7
|
Health Risk |
Pathogenic |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS1963758780 |
BBS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS1963835517 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoinflammatory syndrome, Blau syndrome |
| RS1963867873 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS1963874583 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS1963877282 |
NUP93
|
Health Risk |
Likely pathogenic |
— |
| RS1963877824 |
ALPK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1963883799 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS1963884904 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1963887200 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
COL4A4-related disorder, Alport syndrome |
| RS1963891093 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS1963891935 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS1963898125 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS1963907888 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS1963937785 |
KIF7
|
Health Risk |
Likely pathogenic |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS1964000214 |
RPGRIP1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1964001995 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1964065704 |
KIF7
|
Health Risk |
Pathogenic |
Acrocallosal syndrome, Multiple epiphyseal dysplasia |
| RS1964095605 |
ATP2A1
|
Health Risk |
Likely pathogenic |
Brody myopathy, ATP2A1-related disorder |
| RS1964105013 |
ATP2A1
|
Health Risk |
Likely pathogenic |
Brody myopathy, Brody myopathy |
| RS1964119065 |
ATP2A1
|
Health Risk |
Pathogenic |
Brody myopathy, Brody myopathy |
| RS1964121186 |
ATP2A1
|
Health Risk |
Pathogenic |
Brody myopathy, Brody myopathy |
| RS1964134678 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1964154734 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS1964155109 |
BBS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome |
| RS1964237631 |
ALG9
|
Health Risk |
Likely pathogenic |
ALG9 congenital disorder of glycosylation, ALG9 congenital disorder of glycosylation |
| RS1964267396 |
BBS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS1964269329 |
BBS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS1964318459 |
SLC12A3
|
Health Risk |
Pathogenic |
— |
| RS1964322654 |
SLC12A3
|
Health Risk |
Pathogenic |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS1964333023 |
PLIN1
|
Health Risk |
Pathogenic |
PLIN1-related familial partial lipodystrophy, PLIN1-related familial partial lipodystrophy |
| RS1964403206 |
CIT
|
Health Risk |
Likely pathogenic |
Microcephaly 17, primary |
| RS1964413369 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS1964413705 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS1964467589 |
AAGAB
|
Health Risk |
Pathogenic |
— |
| RS1964520477 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Blau syndrome, Regional enteritis |
| RS1964523180 |
TK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial disease, Mitochondrial DNA depletion syndrome |
| RS1964531402 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS1964531867 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS1964549329 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1964549409 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1964558577 |
BBS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome |
| RS1964561986 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1964569500 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS1964662122 |
TK2
|
Health Risk |
Pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS1964674209 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS1964676419 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS1964676925 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS1964759975 |
CD19
|
Health Risk |
Pathogenic |
— |
| RS1964866367 |
BBS2
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1965024310 |
TK2
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome, myopathic form |
| RS1965109135 |
TK2
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome, myopathic form |
| RS1965287605 |
EARS2
|
Health Risk |
Pathogenic |
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome, Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome |
| RS1965289455 |
EARS2
|
Health Risk |
Pathogenic |
— |
| RS1965305721 |
TK2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |